Please Wait...

Events

Bioclinica will be exhibiting, attending and hosting numerous events in the coming months, from bio-imaging events to clinical data conferences. Please check our schedule of activities and trade shows, and come visit with us when we are in your area.

Directions:
Use the Filter Events By Month below to select the specific Month and Year you would like to see.

June 27, 2017 - 11:00am (EDT)

In a 2016 CenterWatch survey of 252 global investigative sites, the organization found that "e-clinical technologies are increasing investigative site work burden and performance inefficiencies." With investigative sites under increasing resource constraints, they are becoming far more selective in the companies they choose to do business with.

Event Type: Webinar

June 28, 2017 - 1:00am (EDT) to June 29, 2017 - 1:00am (EDT)

OCT UK & Ireland 2017

Bioclinica is delighted to sponsor Outsourcing in Clinical Trials United Kingdom and Ireland.

Event Type: Conference

July 14, 2017 - 1:00am (EDT) to July 20, 2017 - 1:00am (EDT)

Alzheimer's Association International Conference

Join Bioclinica for AAIC 2017, where international investigators, clinicians and care providers gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.

Attend oral and poster sessions by Bioclinica's Neuroscience team and meet Bioclinica representatives from our Medical Imaging and Biomarkers and Global Clinical Research business segments.

Event Type: Conference

September 6, 2017 - 1:00am (EDT) to September 7, 2017 - 1:00am (EDT)

Outsourcing in Clinical Trials New England
Join Bioclinica in Boston for OCT New England on September 6-7. Our team is happy to answer any questions you might have about Medical Imaging, Cardiac Safety, Biomarkers, Post-Approval Research, Patient Recruitment & Retention, and eHealth technologies.
Event Type: Conference

September 24, 2017 - 1:00am (EDT) to September 27, 2017 - 1:00am (EDT)

SCDM 2017

Our eHealth Solutions team hopes to see you at SCDM in Orlando! We invite you to join Bioclinica eHealth Solutions Director, Data Strategy and Solutions Karen McPoyle for her Session 1 discussion on Sept. 25th from 10:45 am to 12:15, Answering the Age Old Question, "Are We There Yet?"

Event Type: Conference

October 5, 2017 - 1:00am (EDT) to October 8, 2017 - 1:00am (EDT)

Global Site Solutions Summit
Join Bioclinica in Boca Raton, Florida for the Global Site Solutions Summit on October 5-8 where we are delighted to be a premier sponsor and exhibitor. Our Research Network and Financial Lifecycle Solutions will be sharing its extensive experience in a presentation geared toward the site perspective.
Event Type: Conference

November 2, 2017 - 1:00am (EDT) to November 3, 2017 - 1:00am (EDT)

14th Annual Patient Summit USA 2017

If you believe that the pharma industry's focus should be all about the patient, make sure you are one of 300+ senior pharma executives, regulatory authorities, providers, payers, advocates and patients who will come together to drive change at the Patient Summit USA – where Bioclinica is a Sponsor and a Speaker.

Event Type: Conference
Risk-Based Trial Management & Monitoring
Join members of Bioclinica's eClinical team in Philadelphia and learn about our industry-leading risk-based trial management and monitoring solutions.
Event Type: Conference

November 28, 2017 - 1:00am (EST) to November 29, 2017 - 1:00am (EST)

Partnerships in Clinical Trials, Europe
Bioclinica and our team of experts across all three business segments look forward to PCT Europe in Amsterdam. This is an exceptional opportunity to have a one-on-one with a senior member of Bioclinica, see demonstrations of our industry-leading technologies in our exhibit, and learn about all of the exciting technology innovations and extensive resources that are available to support both sponsors and CROs in the conduct of successful clinical trials. See you in Amsterdam!
Event Type: Conference

On Demand Webinars by Category

 

Electronic Data Capture (EDC) and Data Management

CDISC Standards Briefing – Get Ready for FDA Submissions
Join Jennifer in this webinar for a detailed briefing on where we stand with CDISC implementation and what's next. Learn about recent activities surrounding CDISC standards, which support the acquisition, exchange, submission and archive of clinical research data and metadata and are accessed in 90 countries.

 

Clinical Trial Management Systems (CTMS)

Bridging the Gap: Managing and Maintaining CTMS and eTMF Data
In this webinar, clinical trial experts Dirk Beth of arivis, a Bioclinica App xChange Partner, and Bioclinica's Jeremiah Rehm will explore the possibilities of single source data across CTMS/eTMF systems. This approach can bring increased efficiencies in a number of important areas, such as elimination of redundant work processes and reconciliation of CTMS/eTMF data.

Back to Top

 

Randomization and Trial Supply Management (RTSM)

Agile IRT is here! How can you benefit?
Bioclinica experts will show how evolved software development is being applied to IRT study builds to bring about better timelines, visibility and – most importantly – quality. Participants will find out how leading pharma organizations are already employing live study demos and feedback loops, and as a result, experiencing significant advantages of Agile IRT over conventional IRT build – in many important and unexpected ways.

 

What Value Does Forecasting and Demand Planning Technology Bring to the Management of the End-to-end Clinical Supply Chain?
Forecasting and demand planning tools provide insight to what is truly happening in a clinical trial. They give the transparency required to make timely and educated decisions with regards to clinical trial supply plans and connect people and processes to streamline the forecasting, planning and optimization of the supply chain.

 

Risk-Based Monitoring

ICH E6 R2 - Guidance and Road Map of Tools for Navigating the Regulatory Landscape
ICH E6 R2 may be relatively new, but the team at The Avoca Quality Consortium (AQC) has been working on many of the components of this set of regulatory changes for over five years.

 

What Effect Does ICH E6 R2 Have on Risk-Based Monitoring and Overall Quality Risk Management?
With the aim of improving efficiencies in trial conduct while ensuring participant safety, regulatory guidelines have recently undergone revision. The revision to the ICH Guideline for Good Clinical Practice (E6 R2) primarily addresses quality management with a focus on risk identification, evaluation, control, review and reporting. With the pending adoption of these revised guidelines, it's time to evaluate how your organizational structure and processes will be affected.

Back to Top

 

Post-Approval Research

Patient Centric Post-Approval Research: It's Time to Rethink How Post-Approval Studies Are Done
With an evolving role and complexities of post-approval studies – and a shift toward patient centric outcomes – it is imperative that we revisit the way post-approval research is conducted.

 

Conducting Post-Approval Research Requires a Unique Mindset and Specialized Infrastructure. Do You Have What it Takes?
There are fundamental differences in conducting research in pre-market randomized controlled trials (RCT) versus post-approval. These differences are not only in the study intent and objectives but the operations and conduct.

 

Safety and Relgulatory Solutions

Cloud-Based Tool Aims to Improve Global Drug Safety & Regulatory Efficiencies While Remaining Compliant
Keeping up with the increasing and evolving safety and pharmacovigilance obligations around the globe can be a major challenge.

In this webinar, she will discuss upcoming changes in global drug safety regulatory requirements and will demonstrate how Bioclinica's drug safety regulatory intelligence tool, RITrace, can improve efficiencies and help you remain compliant.

 

Marketing Medicines in the EU - Pharmacovigilance Requirements
In this complimentary webinar the Chief Safety Advisor for Synowledge (a Bioclinica company) provides expert insight into good pharmacovigilance practices (GVP) modules within EU legislation. Any pharmaceutical company wishing to market products within the EU must be aware of their legal requirements under the legislation. This webinar is suitable for all staff working in the safety and regulatory area. It is an opportunity to gain an understanding of the legislation at a high level and ask specific questions relating to your business.

 

Finding the Right End-to-End Safety Solution for Your Needs
With upcoming changes, including the implementation of E2B(R3) and IDMP standards, the current state of safety reporting in clinical trials can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets in the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.

 

Financial Lifecycle Solutions

Clinical Trial Forecasting: Managing the Challenges and Avoiding the Fines
With globalization, large numbers of sites, recent regulatory requirements and an increasing number of CROs and vendors, clinical trials are constantly becoming more complex. Given that clinical trial costs are one of the biggest expense categories for biopharmaceutical companies—the average cost of bringing a drug to market in the US is estimated to be $1.3-1.7 billion—it's critical that CROs and Sponsors forecast accurately.

However, manual processes have made forecasting of clinical trials challenging, leading to difficulties in reforecasting and cash management (and as a result, difficulties in maintaining site satisfaction) as well as hefty fines.

 

Medical Imaging

Critical Regulatory Considerations for Imaging Trials: What You Need to Know
Medical Imaging plays a significant role in the conduct of clinical trials and bringing new therapies to market. However, as application of medical imaging in clinical studies grow, so does the complexity of regulations on a trial's conduct. The more sites, patients and modalities in a trial, the more complex the regulatory and workflow compliance.

Back to Top

 

Cardiac Safety

Recent Advances and Critical Review of The Intensive QT Study As a Replacement to The TQT Study: Are We There Yet?
In July 2013 the US FDA presented an initiative to replace the ICH-E14 mandated Thorough QT (TQT) study with a set of non-clinical assays, collectively termed 'Comprehensive In Vitro Pro-arrhythmia Assay' (CiPA). The non-clinical CiPA paradigm is complemented by an Early Phase cardiac safety assessment, involving routine Phase 1 single and multiple ascending dose (SAD/MAD) studies with intensive ECG (QT) and PK sampling, designated the Intensive QT (IQT) study.

Back to Top

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

ICYMI: Clean Patient Optics: helping #ClinicalResearch teams meet or beat database lock. News https://t.co/pUem5e2cMG
bioclinica (25 minutes ago)
Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
bioclinica (5 days ago)

Latest Blogs: